MAGNA Pharmaceuticals Selects LSPediA for DSCSA Serialization

 

LOUISVILLE, Ky., Aug. 2, 2018 /PRNewswire/ -- LSPediA, a leading software and service provider for the pharmaceutical industry, today announced a new business relationship with MAGNA Pharmaceuticals.

MAGNA specializes in supplying high-quality prescription and consumer products to health care providers contracted under the U.S. Department of Veterans Affairs and the civilian market. Meeting federal and state compliance requirements is a proud tradition and a non-negotiable commitment for MAGNA. The 10-year vision of the FDA's 2013 Drug Supply Chain Security Act enforces new and stringent requirements to strengthen the U.S. drug supply chain and eradicate drug counterfeiting.

"Patient safety is paramount in our mission, in addition to providing efficacious and affordable products/services for patients and other health care stakeholders," said Warren Lesser, Ph.D., CEO of MAGNA Pharmaceuticals. "Partnering with LSPediA enables DSCSA compliance and augments our supply chain operations. The cloud technology and RF mobile scanners automate our processes to quickly trade and distribute serialized products with 100% accuracy, contributing to overall health care delivery."

By leveraging RxChain®, MAGNA Pharmaceuticals enables Track and Trace, Serialization, shipment aggregation, and seamless data exchange with trading partners and provides full FDA DSCSA compliance now and for the future.

"Our software is built for companies like MAGNA to advance supply chain and meet compliance," said Riya Cao, LSPediA CEO. "RxChain®'s Cloud Solution, mobile technology, and best-in-practice workflow serve as a robust serialization platform for MAGNA's daily operations. When we take on the heavy lifting of compliance and serialization, our customers can focus on their core business and flourish."

About MAGNA Pharmaceuticals, Inc.®

MAGNA Pharmaceuticals, Inc® is a privately-owned U.S. company based in Louisville, KY, which specializes in bringing to market high-quality, safe, and affordable pharmaceutical products and dietary supplements. Formed in 2000 with accountability as a core value, MAGNA is dedicated to patient safety and compliance with the FDA, DEA, and the Kentucky Board of Pharmacy.

Learn more about MAGNA Pharmaceuticals at http://www.magnaweb.com.

About LSPediA - Life Sciences Solutions

LSPediA is a leading supply chain software provider for the pharmaceutical industry. LSPediA's serialization solution RxChain® protects pharma companies against counterfeit and regulatory risks, and improves supply chain efficiency through automation, integration, and mobile computing. Pharmaceutical manufacturers, wholesale distributors, dispensers, and healthcare providers partner with LSPediA to manage serial data, serial warehouse, and serial data exchange with trading partners.

Contact (248) 973-2008, info@lspedia.com, or visit www.lspedia.com to learn more.

Media contact:
Tara Boinpally
199492@email4pr.com
(248) 329-1120

View original content with multimedia:http://www.prnewswire.com/news-releases/magna-pharmaceuticals-selects-lspedia-for-dscsa-serialization-300690989.html

SOURCE LSPediA LLC

Back to news